Global Anatomic Pathology Market

Global Anatomic Pathology Market Size, Share, Growth Analysis, By Product and Service(Consumables, Instruments), By Application(Disease Diagnosis, Medical Research), By End-User(Hospitals, Clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35E2013 | Region: Global | Published Date: February, 2024
Pages: 265 | Tables: 89 | Figures: 76

Global Anatomic Pathology Market Insights

Anatomic Pathology Market size was valued at USD 35.21 billion in 2019 and is poised to grow from USD 37.71 billion in 2023 to USD 65.54 billion by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

An extensive rise in the use of clinical biomarkers to determine diseases pathogenesis at very molecular level enables the pathologists to enhance clinical decision making and improve patient outcomes are the factors anticipated to drive the growth of the global anatomic pathology market over the forecast period. Furthermore, the rising prevalence of biomarker-based pathology tests and further procedures for the exploration of malignancy and tumorigenesis is also driving the global demand and growth for anatomic pathology in the coming years.

Moreover, high usage of advanced technology in pathology equipment such as staining systems, digital microscopes, and gross imaging and adoption of these technologies in developing countries such as India and China are expected to foster market growth during the forecast period. Additionally, several major companies are focusing on development and improvement of pathology devices along with the design and ease of use. For instance, in May 2021, OptraSCAN, a leading pathology solutions provider introduced its new and advanced CytoSiA-an intelligent solution for fast scanning, analysis of pap smears, and at an affordable cost.

In addition, various business partnerships, collaborations, and agreement ventures among key market players for the introduction to new and innovative products and expanding their product portfolio are also projected to fuel the demand for global anatomic pathology market during the forecast period. For instance, in April 2021, Royal Philips announced its collaboration with Ibex Medical Analytics, an AI-based cancer diagnostics service provider. The main aim behind this collaboration is to boost the adoption and implement of AI-based pathology across the globe.

US Anatomic Pathology Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Anatomic Pathology Market size was valued at USD 35.21 billion in 2019 and is poised to grow from USD 37.71 billion in 2023 to USD 65.54 billion by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

Global anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Becton, Dickinson and Company', 'Hologic, Inc.', 'Sakura Finetek Japan Co., Ltd.', 'Agilent Technologies, Inc.', 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'Siemens AG', 'Cell Signaling Technology, Inc.', 'PerkinElmer Inc.', 'Enzo Life Sciences, Inc.', 'Abcam plc', 'Epitomics, Inc.', 'Biocare Medical, LLC', 'Ventana Medical Systems, Inc.', 'Leica Biosystems Nussloch GmbH'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the global anatomic pathology market during the forecast period. According to our findings, the global population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the global population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the global market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.

Anatomic Pathology Market size was valued at USD 35.21 billion in 2021 and is poised to grow from USD 37.71 billion in 2022 to USD 65.54 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Global anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Becton, Dickinson and Company', 'Hologic, Inc.', 'Sakura Finetek Japan Co., Ltd.', 'Agilent Technologies, Inc.', 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'Siemens AG', 'Cell Signaling Technology, Inc.', 'PerkinElmer Inc.', 'Enzo Life Sciences, Inc.', 'Abcam plc', 'Epitomics, Inc.', 'Biocare Medical, LLC', 'Ventana Medical Systems, Inc.', 'Leica Biosystems Nussloch GmbH'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the global anatomic pathology market during the forecast period. According to our findings, the global population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the global population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the global market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Anatomic Pathology Market

Report ID: UCMIG35E2031 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Canine Orthopedics Market
Buy Now GET FREE SAMPLE
Global Anatomic Pathology Market

Report ID: UCMIR35E2049 | Region: Regional | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

U.S. Ambulatory Surgical Centers Market
Buy Now GET FREE SAMPLE
Global Anatomic Pathology Market

Report ID: UCMIG35E2046 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Flea, Tick, And Heartworm Products Market
Buy Now GET FREE SAMPLE
Global Anatomic Pathology Market

Report ID: SQMIG35E2021 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 67 | Figures: 75

Global FMD Disease Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Anatomic Pathology Market

Product ID: SQMIG35E2013

$5,300
BUY NOW GET FREE SAMPLE